Zealand Pharma — Februar 2022
-
Gadbois det var et meget beskedent kursmål. Hvad bygger du det på. Tror du at Glepaglutide fejler. Eller mener du ikke at Zealand er mere værd selv med Glepaglutide godkendt/på marked. Husk at Shire i 2015 betalte 5,2 mia. USD for NPS Pharmaceutical, hvis hovedprodukt ”Gattex” var netop mod SBS.
-
Måske en ældre Storm P. kan hjælpe lidt på humøret..., Pessimisten til optimisten: "nu kan det da ikke blive meget værre?!" - optimisten til pessimisten: " ork jo, det kan det da sagtens!?!"
-
tak
-
Der er lige her Swingtrader.
-
tak chef:)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind